dsm-firmenich has secured European market access for its 3-fucosyllactose (3-FL) ingredient, one of the most abundant human milk oligosaccharides (HMO) in human milk.
dsm-firmenich has secured European market access for its 3-fucosyllactose (3-FL) ingredient, one of the most abundant human milk oligosaccharides (HMO) in human milk.
Human milk oligosaccharides (HMOs) are now officially permitted for use in China’s infant formula, with two multinationals, namely IFF and dsm-firmenich, as well as local diary giant Mengniu, announcing that they have received approvals in the past week.
The US FDA has issued ‘Good Day Letters’ to dsm-firmenich for three Generally Recognized as Safe (GRAS) notices submitted for the human milk oligosaccharides (HMOs) LNFP-l/2’-FL and hypoallergenic grade LNnT and 2’-FL.
The US FDA has issued ‘Good Day Letters’ to dsm-firmenich for three Generally Recognized as Safe (GRAS) notices submitted for the human milk oligosaccharides (HMOs) LNFP-l/2’-FL and hypoallergenic grade LNnT and 2’-FL.